ArticleJCI insight2026

CRISPR/Cas9 loss-of-function screen in a neuronal model of AP-4 deficiency identifies ATG9A trafficking modulators.

Marvin Ziegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.